Competitive Technologies has signed an agreement with Excel Life Sciences granting them exclusive distribution rights in India for the company's pain management therapy device.

Hansen Medical has received the FDA 510(k) clearance to market the CoHesion 3D visualization module for use in complex electrophysiology mapping procedures.

Impliant has resumed European clinical activities on its Tops system, a total posterior arthroplasty device designed to treat spinal stenosis with or without facet arthrosis and spondylolisthesis.

Response Biomedical has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of-care tests worldwide.

Phase Forward has launched the Empirica Signal product, a new release of the company's flagship signal detection and management software formerly known as WebVDME.

Advanced Medical Isotope has entered into an agreement to further develop a proprietary brachytherapy treatment with Battelle, which operates the Pacific Northwest National Laboratory, and the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah.

A new report from Datamonitor highlights the increasing importance of signal detection technologies in the pharmacovigilance activities of the drugmakers, according to PharmaTimes.

Although many newer pharmacovigilance solutions are still in the nascent stages, and despite pharmaceutical companies' reluctance to adopt them, it is becoming increasingly obvious that these tools will play an essential role in protecting public health. As drug safety regulations increase, signal...